BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » About Us » Management

Management

  • Per-Olof Berggren
    Per-Olof Berggren
    Member of the Board since 2007. Professor in Experimental Endocrinology and Director of The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden. Visiting Professor at the University of Miami, Miller School of Medicine, USA, Visiting Professor at Postech, Pohang, Korea, Distinguished Professor at the University of Rome Tor Vergata, Italy, Visiting ...
    Read More »
  • James Hall
    James Hall
    Acting COO.  James has 20 years industry experience, including 12 years with AstraZeneca.  While there, he held a number of commercial, R&D and Bus Dev roles, including VP Global Marketing for CV/GI Therapy Area, Global Product VP for Crestor and most recently VP Evaluation for the CV/Metabolism Therapy Area.  Prior to this he was a ...
    Read More »
  • Catharina Liljeryd
    Catharina Liljeryd
    CFO in Biocrine since 2007. B.Sc. in Biology from Stockholm University. More than 30 years of experience in business management, mainly in the IT, Life Science and biotech industry. 

About Us

  • Company and people
  • Board of Directors
  • Management
  • Partners

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved